Cerebral Venous Thrombosis Clinical Presentation

  • Author: W Alvin McElveen, MD; Chief Editor: Helmi L Lutsep, MD   more...
 
Updated: May 16, 2012
 

History

Patients with cerebral venous thrombosis (CVT) may present with headache.[13] Although thunderclap headache usually indicates subarachnoid hemorrhage (SAH), it may also be seen in sinus thrombosis.

SAH has been described as the presenting event with CVT. CVT should be considered in the workup of SAH, especially when the basilar cisterns are not involved.[14]

Patients with lateral sinus thrombosis may present with a pseudotumor cerebri–like syndrome. Using a technique called auto-triggered elliptic-centric-ordered 3-dimensional gadolinium-enhanced magnetic resonance venography (MRV), Farb et al found that 27 of 29 patients with idiopathic intracranial hypertension had bilateral sinovenous stenosis; this was seen in only 4 of 59 control subjects.[15]

Nausea and vomiting may also be associated with CVT. In some cases, seizures, which can be recurrent, occur. Some patients may experience a decreased level of consciousness that progresses to coma.

Focal neurologic deficit may develop, depending on the area involved. Hemiparesis may occur, and in some cases of sagittal sinus thrombosis, weakness may develop in the lower extremity. This also may occur as bilateral lower extremity involvement. Aphasia, ataxia, dizziness, chorea, and hemianopia all have been described.

Cranial nerve syndromes are seen with venous sinus thrombosis. These include the following:

  • Vestibular neuronopathy
  • Pulsatile tinnitus
  • Unilateral deafness
  • Double vision
  • Facial weakness
  • Obscuration of vision

Site of headache versus location of sinus involvement

Wasay et al found little association between headache location and the site of sinus involvement in patients with CVT. In their study, the authors described the pattern and location of headache in 200 consecutive patients with a proven diagnosis of CVT to identify an association between the site of the headache and location of sinus involvement. The quality of headache was reported as throbbing (9%), bandlike (20%), thunderclap (5%), and other (pounding, exploding, stabbing, etc) (20%).

The authors found no association between headache location and the site of sinus thrombosis except in cases of sigmoid sinus thrombosis, in which 17 of 28 patients (61%) with involvement of the sigmoid sinus alone or in combination with the transverse sinus had pain in the occipital and neck region. There was no association between lateralization of pain and the site of thrombosis.[16]

Next

Physical Examination

The effect of cerebral venous thrombosis (CVT) on mental status is quite variable, with some patients showing no change in alertness, others developing mild confusion, and still others progressing to coma.

Cranial nerve findings may include papilledema, hemianopia, oculomotor and abducens palsies, facial weakness, and deafness. If the thrombosis extends to the jugular vein, the patient may develop involvement of cranial nerves IX, X, XI, and XII with the jugular foramen syndrome.

Thrombosis of the superior sagittal (longitudinal) sinus may present with unilateral paralysis that then extends to the other side secondary to extension of the clot into the cerebral veins. Because of the location, this may present as a unilateral lower extremity weakness or paraplegia.

Cavernous sinus thrombosis with obstruction of the ophthalmic veins may be associated with proptosis and ipsilateral periorbital edema. Retinal hemorrhages and papilledema may be present. Paralysis of extraocular movements, ptosis, and decreased sensation in the first division of the trigeminal nerve often are observed.

Although unusual, cortical vein thrombosis may be seen in the absence of dural sinus involvement. These cases are associated with varied focal deficits, including aphasia, hemiparesis, hemisensory loss, and hemianopia.

Previous
Proceed to Differential Diagnoses
 
 
Contributor Information and Disclosures
Author

W Alvin McElveen, MD  Director, Stroke Unit, Lakewood Ranch Medical Center; Neurologist, Manatee Memorial Hospital

W Alvin McElveen, MD is a member of the following medical societies: American Academy of Neurology, American Medical Association, American Society of Neuroimaging, American Stroke Association, and Southern Clinical Neurological Society

Disclosure: Nothing to disclose.

Coauthor(s)

Andrew P Keegan, MD  Private Practice, Bradenton Neurology, Inc; Consulting Staff, Department of Neurology, Manatee Memorial Hospital, Lakewood Ranch Medical Center, Blake Medical Center

Andrew P Keegan, MD is a member of the following medical societies: American Academy of Neurology and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Helmi L Lutsep, MD  Professor and Vice Chair, Department of Neurology, Oregon Health and Science University School of Medicine; Associate Director, Oregon Stroke Center

Helmi L Lutsep, MD is a member of the following medical societies: American Academy of Neurology and American Stroke Association

Disclosure: Co-Axia Consulting fee Review panel membership; AGA Medical Consulting fee Review panel membership; Concentric Medical Consulting fee Review panel membership

Additional Contributors

Ralph F Gonzalez, MD Private Practice, Bradenton Neurology, Inc; Consulting Staff, Department of Neurology, Blake Hospital, Lakewood Ranch Medical Center, Manatee Memorial Hospital

Ralph F Gonzalez, MD is a member of the following medical societies: American Academy of Neurology and Florida Medical Association

Disclosure: Nothing to disclose.

Howard S Kirshner, MD Professor of Neurology, Psychiatry and Hearing and Speech Sciences, Vice Chairman, Department of Neurology, Vanderbilt University School of Medicine; Director, Vanderbilt Stroke Center; Program Director, Stroke Service, Vanderbilt Stallworth Rehabilitation Hospital; Consulting Staff, Department of Neurology, Nashville Veterans Affairs Medical Center

Howard S Kirshner, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Heart Association, American Medical Association, American Neurological Association, American Society of Neurorehabilitation, National Stroke Association, Phi Beta Kappa, and Tennessee Medical Association

Disclosure: Nothing to disclose.

Norman C Reynolds Jr, MD Neurologist, Veterans Affairs Medical Center of Milwaukee; Clinical Professor, Medical College of Wisconsin

Norman C Reynolds Jr, MD is a member of the following medical societies: American Academy of Neurology, Association of Military Surgeons of the US, Movement Disorders Society, Sigma Xi, and Society for Neuroscience

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References

  1. Cesarman-Maus G, Cantú-Brito C, Barinagarrementeria F, Villa R, Reyes E, Sanchez-Guerrero J. Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis. Stroke. Feb 2011;42(2):501-3. [Medline].

  2. Schievink WI, Maya MM. Cerebral venous thrombosis in spontaneous intracranial hypotension. Headache. Nov-Dec 2008;48(10):1511-9. [Medline]. [Full Text].

  3. Canhão P, Batista P, Falcão F. Lumbar puncture and dural sinus thrombosis--a causal or casual association?. Cerebrovasc Dis. 2005;19(1):53-6. [Medline].

  4. Ennaifer R, Moussa A, Mouelhi L, et al. Cerebral venous sinus thrombosis as presenting feature of ulcerative colitis. Acta Gastroenterol Belg. Jul-Sep 2009;72(3):350-3. [Medline].

  5. Towbin A. The syndrome of latent cerebral venous thrombosis: its frequency and relation to age and congestive heart failure. Stroke. May-Jun 1973;4(3):419-30. [Medline].

  6. Daif A, Awada A, al-Rajeh S, et al. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke. Jul 1995;26(7):1193-5. [Medline].

  7. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. Feb 1992;10(1):87-111. [Medline].

  8. Galarza M, Gazzeri R. Cerebral venous sinus thrombosis associated with oral contraceptives: the case for neurosurgery. Neurosurg Focus. Nov 2009;27(5):E5. [Medline].

  9. Smith AG, Cornblath WT, Deveikis JP. Local thrombolytic therapy in deep cerebral venous thrombosis. Neurology. Jun 1997;48(6):1613-9. [Medline].

  10. Ferro JM, Crassard I, Coutinho JM, Canhão P, Barinagarrementeria F, Cucchiara B. Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient data. Stroke. Oct 2011;42(10):2825-31. [Medline].

  11. Ferro JM, Lopes MG, Rosas MJ, et al. Long-Term Prognosis of Cerebral Vein and Dural Sinus Thrombosis. results of the venoport study. Cerebrovasc Dis. 2002;13(4):272-8. [Medline].

  12. Buccino G, Scoditti U, Patteri I, et al. Neurological and cognitive long-term outcome in patients with cerebral venous sinus thrombosis. Acta Neurol Scand. May 2003;107(5):330-5. [Medline].

  13. Flores-Barragan JM, Hernandez-Gonzalez A, Gallardo-Alcaniz MJ, Del Real-Francia MA, Vaamonde-Gamo J. [Clinical and therapeutic heterogeneity of cerebral venous thrombosis: a description of a series of 20 cases.]. Rev Neurol. Dec 1-15 2009;49(11):573-6. [Medline].

  14. Oppenheim C, Domigo V, Gauvrit JY, et al. Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis. AJNR Am J Neuroradiol. Mar 2005;26(3):614-7. [Medline].

  15. Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. May 13 2003;60(9):1418-24. [Medline].

  16. Wasay M, Kojan S, Dai AI, Bobustuc G, Sheikh Z. Headache in Cerebral Venous Thrombosis: incidence, pattern and location in 200 consecutive patients. J Headache Pain. Apr 2010;11(2):137-9. [Medline].

  17. Tardy B, Tardy-Poncet B, Viallon A, et al. D-dimer levels in patients with suspected acute cerebral venous thrombosis. Am J Med. Aug 15 2002;113(3):238-41. [Medline].

  18. Lalive PH, de Moerloose P, Lovblad K, et al. Is measurement of D-dimer useful in the diagnosis of cerebral venous thrombosis?. Neurology. Oct 28 2003;61(8):1057-60. [Medline].

  19. Kosinski CM, Mull M, Schwarz M, et al. Do normal D-dimer levels reliably exclude cerebral sinus thrombosis?. Stroke. Dec 2004;35(12):2820-5. [Medline].

  20. Ozsvath RR, Casey SO, Lustrin ES, et al. Cerebral venography: comparison of CT and MR projection venography. AJR Am J Roentgenol. Dec 1997;169(6):1699-707. [Medline].

  21. Mas JL, Meder JF, Meary E, Bousser MG. Magnetic resonance imaging in lateral sinus hypoplasia and thrombosis. Stroke. Sep 1990;21(9):1350-6. [Medline].

  22. Adams WM, Laitt RD, Beards SC, et al. Use of single-slice thick slab phase-contrast angiography for the diagnosis of dural venous sinus thrombosis. Eur Radiol. 1999;9(8):1614-9. [Medline].

  23. Ayanzen RH, Bird CR, Keller PJ, et al. Cerebral MR venography: normal anatomy and potential diagnostic pitfalls. AJNR Am J Neuroradiol. Jan 2000;21(1):74-8. [Medline].

  24. Medel R, Monteith SJ, Crowley RW, Dumont AS. A review of therapeutic strategies for the management of cerebral venous sinus thrombosis. Neurosurg Focus. Nov 2009;27(5):E6. [Medline].

  25. Bentley JN, Figueroa RE, Vender JR. From presentation to follow-up: diagnosis and treatment of cerebral venous thrombosis. Neurosurg Focus. Nov 2009;27(5):E4. [Medline].

  26. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. Sep 7 1991;338(8767):597-600. [Medline].

  27. de Bruijn SF, Stam J, Vandenbroucke JP. Increased risk of cerebral venous sinus thrombosis with third- generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group. Lancet. May 9 1998;351(9113):1404. [Medline].

  28. Rahman M, Velat GJ, Hoh BL, Mocco J. Direct thrombolysis for cerebral venous sinus thrombosis. Neurosurg Focus. Nov 2009;27(5):E7. [Medline].

  29. Ekseth K, Bostrom S, Vegfors M. Reversibility of severe sagittal sinus thrombosis with open surgical thrombectomy combined with local infusion of tissue plasminogen activator: technical case report. Neurosurgery. Oct 1998;43(4):960-5. [Medline].

  30. Alonso-Canovas A, Masjuan J, Gonzalez-Valcarcel J, et al. [Cerebral venous thrombosis: when etiology makes the difference.]. Neurologia. Sep 2009;24(7):439-45. [Medline].

  31. Benamer HT, Bone I. Cerebral venous thrombosis: anticoagulants or thrombolyic therapy?. J Neurol Neurosurg Psychiatry. Oct 2000;69(4):427-30. [Medline].

  32. Cipri S, Gangemi A, Campolo C, et al. High-dose heparin plus warfarin administration in non-traumatic dural sinuses thrombosis. A clinical and neuroradiological study. J Neurosurg Sci. Mar 1998;42(1):23-32. [Medline].

  33. D'Alise MD, Fichtel F, Horowitz M. Sagittal sinus thrombosis following minor head injury treated with continuous urokinase infusion. Surg Neurol. Apr 1998;49(4):430-5. [Medline].

  34. Davis KR, Kistler JP, Buonanno FS. Clinical neuroimaging approaches to cerebrovascular diseases. Neurol Clin. Nov 1984;2(4):655-65. [Medline].

  35. Gold Standard Multimedia. Urokinase, Altevase, Streptokinase, Heparin, Warfarin. Clinical Pharmacology. 2000;Available at:http://cp.gsm.com/. [Full Text].

  36. Gomez CR, Misra VK, Terry JB, et al. Emergency endovascular treatment of cerebral sinus thrombosis with a rheolytic catheter device. J Neuroimaging. Jul 2000;10(3):177-80. [Medline].

  37. Gustafsson D, Elg M. The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review. Thromb Res. Jul 15 2003;109 Suppl 1:S9-15. [Medline].

  38. Jacobs K, Moulin T, Bogousslavsky J, et al. The stroke syndrome of cortical vein thrombosis. Neurology. Aug 1996;47(2):376-82. [Medline].

  39. Leys D, Cordonnier C. Cerebral venous thrombosis: Update on clinical manifestations, diagnosis and management. Ann Indian Acad Neurol. 2008;11:79-87. [Full Text].

  40. Meyer-Lindenberg A, Quenzel EM, Bierhoff E, et al. Fatal cerebral venous sinus thrombosis in heparin-induced thrombotic thrombocytopenia. Eur Neurol. 1997;37(3):191-2. [Medline].

  41. Zweifler RM. Management of acute stroke. South Med J. Apr 2003;96(4):380-5. [Medline].

 
Previous
Next
 
Left lateral sinus thrombosis demonstrated on magnetic resonance venography (MRV). This 42-year-old woman presented with sudden onset of headache. Physical examination revealed no neurologic abnormalities.
Same patient as in the previous image. One week after treatment with heparin, the magnetic resonance (MR) venogram displayed increased flow in the left lateral sinus consistent with early recanalization of the sinus; headache had resolved at this point.
Magnetic resonance venogram (MRV) - axial view; A = lateral (transverse) sinus; B = sigmoid sinus; C = confluence of sinuses; and D = superior sagittal sinus.
Magnetic resonance venogram (MRV) - sagittal view; A = lateral (transverse) sinus; C = confluence of sinuses; D = superior sagittal sinus; and E = straight sinus.
Computed tomography (CT) scan demonstrates a left posterior temporal hematoma in a 38-year-old woman on oral contraceptives (the only identified risk factor).
Contrast-enhanced magnetic resonance imaging (MRI) scan showing lack of filling of left transverse sinus.
Axial view of magnetic resonance (MR) venogram demonstrating lack of flow in transverse sinus.
Coronal view of magnetic resonance (MR) venogram demonstrating lack of flow in the left transverse and sigmoid sinuses.
Table. Patients With Cerebral Venous Thrombosis Treated With Heparin and Local Infusion of Urokinase vs Nontreated Group
Treated Group, % (n = 12) Nontreated Group, % (n = 21)
Full recovery62.529
Mild disability12.513
Severe disability12.59.6
Fatal outcome12.548
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.